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Objectives To assess employment status, difﬁculties at work and sick leave in inﬂammatory bowel disease (IBD) patients and
their relation with sociodemographic and clinical factors, quality of life (QoL), and anxiety and depression.
Materials and methods IBD patients attending an IBD outpatients’ clinic received self-report questionnaires on employment
status, IBD-related difﬁculties at work and sick leave (Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness),
sociodemographic factors, QoL (Inﬂammatory Bowel Disease Questionnaire and 12-item Short-form Health Survey) and anxiety
and depression (Hospital Anxiety and Depression Scale). Disease activity was assessed by their gastroenterologist. Associations
between paid employment and sick leave with sociodemographic and clinical factors, QoL and anxiety and depression were
assessed by regression analyses.
Results In total, 202 IBD patients of working age, with a mean age of 41 years, participated; 63% had Crohn’s disease and 37%
had ulcerative colitis, and 57% were women and 19% had active disease. In all, 123 (61%) patients were in paid employment, of
whom 31 (25%) were on sick leave, whereas 46 (23%) received a disability pension. Concentration problems (72%), low working
pace (78%) and delayed work production (50%) were the most prevalent IBD-related work difﬁculties. IBD patients without paid
employment were older and more often women, with active disease, lower QoL and higher anxiety and depression rates. Sick
leave was associated with lower QoL and higher anxiety and depression rates.
Conclusion More than half of IBD patients were in paid employment, whereas almost a quarter was receiving a disability
pension. A large majority experienced work difﬁculties. Having no paid employment was associated with poorer QoL and more
anxiety and depression symptomatology. Eur J Gastroenterol Hepatol 28:1130–1136
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Introduction
The prevalence of inﬂammatory bowel disease (IBD) is
relatively high in Europe, with 505 persons affected with
ulcerative colitis (UC) per 100 000 persons and 322 per-
sons per 100 000 persons affected by Crohn’s disease
(CD). Many IBD patients develop intestinal or extra-
intestinal complications and experience adverse treatment
effects [1]. The potentially incapacitating disease course
can represent a heavy burden for patients, impacting every
aspect of the patient’s quality of life (QoL) [1–3].
Typically those in the young working-age population
are affected [4]. The majority of patients with IBD
experience physical, emotional and social problems such
as fatigue, pain, diarrhoea, diminished cognitive func-
tioning, embarrassment and anxiety or depression, which
may result in limitations in social activities including
employment [3]. An important consequence is, therefore, a
reduced ability to work that can have a severe negative
effect on patients’ health-related QoL [5] and that leaves
IBD patients at risk of leaving the labour force [1].
High work disability rates have been reported for IBD
patients compared with the general population [5,6], with
a six- to nine-fold increased risk of disability pension [7].
In a longitudinal study, it was reported that IBD patients
experienced an increased risk for disability pension com-
pared with the general population even 10 years after
disease onset [8]. Disease severity was found to be the most
important predictor of work disability [6,8,9].
In addition, a large proportion of the societal costs
associated with IBD are indirect costs that are associated
with sick leave and early retirement [8]. In the USA, IBD
patients have higher probabilities of missing time from
work and missing workdays than those without IBD [10].
Work productivity is signiﬁcantly impaired in IBD patients
and is associated with high presenteeism and productivity
loss [7].
Because earlier studies have primarily reported on work
outcomes such as sick leave data, little is known about the
difﬁculties that IBD patients themselves experience while
they are working. Furthermore, few data are available on
employment status, IBD-related difﬁculties at work, sick
leave and how they are associated with disease factors and
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QoL outcomes. One Spanish study found that higher
subjective work disability scores in CD patients were
correlated to lower QoL scores and higher number of sick
leave days [11].
Employees with a chronic physical condition such as
IBD may be hampered in job performance and employ-
ment because of physical or cognitive limitations, pain,
fatigue or because medical treatment interferes with work
[12]. Unemployment is associated with anxiety and
depression among IBD patients [13]. Information on IBD-
related work difﬁculties and disease activity, QoL, anxiety
and depression outcomes could thus help clinicians in
detecting those IBD patients at risk for unfavourable
employment outcomes very early in the treatment process
and, if indicated, refer them to occupational care.
The aims of this study are to assess (a) the employment
status of IBD patients and IBD-related difﬁculties at work;
(b) the relationship between the work-related outcomes
employment status and sick leave and sociodemographic
factors, clinical factors, IBD-related difﬁculties at work,
QoL, anxiety and depressive symptoms; and (c) healthcare
utilization and its associations with work-related factors
and QoL.
Materials and methods
Patients and procedures
Consecutive IBD patients who attended the IBD out-
patients’ clinic of the University Hospital of Amsterdam, a
top referral centre, were invited by their treating gastro-
enterologist to participate in the study during their hospital
visit. All patients had IBD, diagnosed by radiography of
the bowel and colon, colonoscopy and endoscopic biopsy.
Patients received an informed consent form to be signed at
home along with a set of self-report questionnaires by
mail. They were asked to return the completed ques-
tionnaire using a prestamped envelope within 2 weeks.
Those who did not respond received a digital reminder
once. The Institutional Review Board (IRB) of the Medical
Ethics Committee of the Academic Medical Center con-
sidered that the Medical Research Involving Human
Subjects Act (WMO) did not apply to the study and that
an ofﬁcial approval of this study by the Committee was
not required.
Measures
Employment status and difﬁculties at work
All measures of employment were assessed using the
Trimbos/iMTA questionnaire for Costs associated with
Psychiatric Illness (TiC-P) as the items were relevant for
IBD [14]. Employment status was assessed as having a
paid job (yes/no). Having no paid job was measured as
either being unemployed/having voluntary work, being
work-disabled, being a student, being a housewife/home-
maker or being an early pensioner. IBD-related work dif-
ﬁculties in the past month including concentration
problems, having to postpone work, having to work
slower and difﬁculties making decisions were assessed with
the TiC-P on a four-point scale, with lower scores indi-
cating fewer problems. In addition, for IBD patients with a
paid job, the extent to which IBD interfered with work
(not, somewhat, very), work presenteeism in the past
month (number of days at work but actually experiencing
health problems) and work efﬁciency in the past 2 weeks
(scale 1–10 from very inefﬁcient to as efﬁcient as normal)
were assessed. Furthermore, number of working hours per
week, number of working days per week, occupation, sick
leave days in the past 2 weeks and income were assessed.
Sociodemographic factors, clinical factors and healthcare
utilization
Sociodemographic variables included sex, age, marital
status and education (primary education, secondary edu-
cation, higher education, college/university). Clinical vari-
ables were assessed by the gastroenterologist and included
disease type (CD, UC), disease activity (yes/no), number of
(IBD-related) operations, duration of disease in years and
undergoing an ileostomy (yes/no). The Harvey Bradshaw
Index [15] was used to assess disease activity of CD
patients and the Truelove and Witts Index [16] assessed
disease activity of UC patients. A score of higher than 4 on
both scales is indicative of disease activity. Healthcare
utilization was assessed with the TIC-P completed by the
patients [14] and included number of visits to the occu-
pational physician, general practitioner (GP), phy-
siotherapist, social worker or outpatient visits to a
specialist during the previous 4 weeks.
Quality of life
Perceived QoL was measured using the 12-item Short-form
Health Survey (SF‐12), an abbreviated version of the SF‐36
[17]. This generic instrument focuses on general health,
physical functioning, mental health, role limitations
because of vitality, physical and mental health, emotional
problems, pain, vitality and social function. Two dimen-
sion scores are derived from the item scores: the Physical
Component Summary (PCS) and the Mental Component
Summary (MCS). Higher SF‐12 scores indicate a higher
level of QoL [18]. The Dutch norm score is 49.4 for PCS
and 51.6 for MCS [17,18].
Disease-speciﬁc QoL was measured using the
Inﬂammatory Bowel Disease Questionnaire (IBDQ) [19]
consisting of 32 items, which are scored on a ﬁve-point
Likert scale. The questions are grouped into four sub-
scales: bowel symptoms, systemic symptoms, emotional
function and social function, and a total score is calculated
[3]. The IBDQ is a reliable and (cross-culturally) valid
instrument [3,20] with a potential score range of 32 to
224, with higher scores indicating better disease-speciﬁc
QoL. Anxiety and depression were measured using the
Hospital Anxiety and Depression Scale (HADS). The scale
contains 14 items consisting of HADS-A (anxiety, seven
questions) and HADS-D (depression, seven questions)
subscales [21]. All items are rated on a four-point scale
(0–3), with higher scores indicating higher levels of
depression and/or anxiety. A score of greater than or equal
to 8 on either subscale indicates a possible psychiatric
disorder (anxiety and/or depressive disorder).
Statistical analyses
Patients more than or equal to 65 years were excluded
from analyses because of the legal retirement age of
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65 years in the Netherlands. Employment status, IBD-
related work problems, sick leave in the last 2 weeks,
sociodemographic and clinical factors, QoL, anxiety and
depression scores and healthcare utilization are described.
Comparison of QoL SF-12 scores, QoL IBDQ scores and
anxiety and depression HADS scores between IBD patients
with a paid job and those without a paid job were analysed
by analysis of covariance corrected for age and sex.
Associations between sick leave (yes/no) with socio-
demographic and clinical factors, QoL, anxiety and
depression, presenteeism, work efﬁciency and other work
problems were analysed by correlations/crosstabs and
(logistic) regression analyses. Associations between disease
activity (yes/no) and presenteeism, work efﬁciency, con-
centration problems at work and working slower were
analysed using nonparametric tests. Associations of
healthcare utilization (number of visits to the occupational
physician, GP, physiotherapist, social worker or outpatient
visits to a specialist) with sociodemographic and clinical
factors, QoL, anxiety and depression and presenteeism,
work efﬁciency and other work problems were analysed by
multiple regression analyses.
Results
We sent self-report questionnaires to 292 consecutive IBD
patients who had attended the IBD Outpatients’ Clinic of
the University Hospital of Amsterdam. In all, 231 com-
pleted questionnaires were returned (79% response rate).
Of these 231 IBD patients, 202 IBD patients (87.4%) were
less than 65 years of age. The mean age of these 202 IBD
patients was 41 years (range 18–64); 116 patients (57%)
were women and most patients were married (70%). Two-
thirds of the patients had CD and one-third had UC, with
19% of the patients in active disease and 8% with ileost-
omy (Table 1).
Employment status, sick leave and work difﬁculties
Table 2 shows that 123 IBD patients were in paid
employment (61%) and 46 IBD patients (23%) were
receiving a disability pension. On average, employed IBD
patients worked 31 h per week. Of the 123 employed
patients, 25% had been on sick leave in the last 2 weeks
and almost half (47%) of the patients reported that their
work had been hindered by health problems in the last
2 weeks. Of the patients who were actually at work, 72%
experienced concentration problems, 78% had to work
slower than normal, 54% had to seclude themselves from
their colleagues and 40% had difﬁculties making deci-
sions. Furthermore, 50% were at work, but their work
production was delayed, whereas for 28% of the patients,
their work had to be done by others.
Paid employment and associations with other factors
Sociodemographic and disease-related factors, and QoL,
anxiety and depression scores for IBD patients with and
without paid employment are shown in Table 3.
IBD patients without paid employment were older (47
vs. 40 years, P<0.001) and more often women (68 vs.
49%, P= 0.02) than those in paid employment. Active
disease was more often present in IBD patients without
paid employment compared with those in paid employ-
ment (28 vs. 13%, P=0.03), but no differences in disease
duration were found (14 vs. 17 years, P=0.41).
Table 1. Sociodemographic and clinical patient characteristics
N=202 patientsa n (%)
Age [mean (range, SD)] (years) 41 (18–64,12)
Disease duration [mean (range, SD)] (years) 15 (0–36, 9.3)
Female 116 (57)
Marital status
Married, living together 141 (70)
Single, divorced, widowed 61 (30)
Disease
Crohn’s disease 128 (63)
Ulcerative colitis 74 (37)
Active disease
Yes 31 (19)
No 134 (81)
Education
Primary education 41 (22)
Secondary education 63 (33)
Higher education 18 (10)
College/university 66 (35)
Ileostomy (yes) 17 (8)
Number of operations
0 110 (55)
≥1 91 (45)
aAs a result of missing data, not all outcomes add up to N=202 patients.
Table 2. Employment outcomes
N=202 patients n (%)
Employment status
Paid employment 123 (61)
Unemployment 1 (0.5)
Housewife/homemaker 12 (6)
Student 11 (5)
Disability pension/work disabled 46 (23)
Early retirement (<65 years) 9 (5)
If in paid employment (N=123a)
Sick leave in the last 2 weeks (yes) 31 (25)
Hours working per week [mean (SD)] 31 (10.2)
Work hindered by health problems in the last 2 weeks
No 58 (52)
Somewhat 45 (40)
Very 8 (7)
At work, but concentration problems
Never 14 (28)
Sometimes 24 (48)
Often 12 (24)
At work, but had to work slower
Never 11 (22)
Sometimes 20 (41)
Often 15 (31)
Almost always 3 (6)
At work, but had to seclude oneself
Never 23 (46)
Sometimes 17 (34)
Often 8 (16)
Almost always 2 (4)
At work, but difﬁculty making decisions
Never 30 (60)
Sometimes 15 (31)
Often 4 (8)
At work, but work delayed
Never 25 (50)
Sometimes 24 (48)
Often 1 (2)
At work, but work had to be done by others
Never 36 (72)
Sometimes 12 (24)
Often 1 (2)
Almost always 1 (2)
aAs a result of missing data, not all outcomes add up to N=123 patients.
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Results of the age-adjusted and sex-adjusted analysis of
covariance of QoL outcomes showed that the PCS scores
(36 vs. 45, P< 0.001), the IBDQ total scores (155 vs. 174,
P< 0.001) and all IBDQ subscale scores (bowel, systemic,
emotional and social; all P<0.005) were signiﬁcantly
lower for IBD patients without paid employment com-
pared with those with paid employment, but the MCS
scores did not differ (45 vs. 47, P= 0.33).
The mean HADS anxiety and depression scores were
6.1 and 4.7, respectively, with 37% of IBD patients having
high anxiety scores indicative of a possible psychiatric
disorder of anxiety and 26% having high depression
scores indicative of a possible psychiatric disorder of
depression. IBD patients without paid employment were
found to have higher scores on anxiety and depression
compared with those with paid employment (7.9 vs. 5.2,
P< 0.001, and 7.2 vs. 3.5, P< 0.001, respectively) as
indicated by age-adjusted and sex-adjusted analysis of
covariance. Furthermore, IBD patients without paid
employment showed statistically signiﬁcantly more often
HADS scores that are indicative of a possible psychiatric
disorder of anxiety and depression compared with IBD
patients with paid employment (48 vs. 30%; P=0.02, and
41 vs. 19%; P= 0.002, respectively).
Sick leave and associations with other factors
Sick leave data of the 123 employed IBD patients are
shown in Table 4. In the last 2 weeks, 31 (25%) of the
employed IBD patients had been on sick leave. No differ-
ences in age (P=0.24), sex (P= 0.38), disease activity
(P= 0.64) or disease duration (P=0.46) were found
between employed IBD patients who had been on sick
leave and those who had not. IBD patients on sick leave
reported statistically signiﬁcantly lower scores with respect
to SF-12 physical (P<00.001) and mental health
(P= 0.005) scores, IBDQ total (P< 0.001), bowel
(P< 0.001), systemic (P< 0.001), emotional (P= 0.001)
and social scores (P<0.001), and HADS anxiety
(P= 00.02) and depression scores (P=0.04) compared
with those not on sick leave. No differences were found
between the groups on the work-related outcomes of
presenteeism (P=0.80), work efﬁciency (P=0.16), con-
centration problems (P= 0.79) and working slower
(P= 0.19). No differences were found between IBD
patients with and without disease activity in presenteeism
(P= 0.62), work efﬁciency (P= 0.15) and problems con-
centrating at work (P= 0.57). However, patients with
active disease more often reported working slower than
patients with no active disease (P=0.03).
Table 3. Differences in sociodemographic, disease-related, QoL, anxiety and depression variables between IBD patients with and without paid
employment
All patients (N=202)a No paid employmentb (N=79)a Paid employment (N=123)a P-value
Age (years) 41 47 40 <0.001
Sex (female) (%) 57 68 49 0.02
Disease activity (yes) (%) 19 28 13 0.03
Disease duration (years) 15 17 14 0.41
QoL: SF-12 [mean (SD)]
Physical Component Score 42 (11) 36 (10) 45 (10) <0.001
Mental Component Score 47 (9) 45 (9) 47 (9) 0.33
QoL: IBDQ [mean (SD)]
IBDQ total 169 (35) 155 (34) 174 (33) <0.001
IBDQ bowel 53 (11) 50 (11) 55 (11) 0.004
IBDQ systemic 23 (7) 19 (7) 24 (6) <0.001
IBDQ emotional 64 (13) 60 (14) 65 (13) 0.004
IBDQ social 28 (7) 25 (7) 29 (7) <0.001
Anxiety: HADS [mean (SD)] 6.1 (4) 7.9 (4) 5.2 (4) <0.001
Anxiety (HADS≥8) [n (%)] 73 (37) 26 (48) 37 (30) 0.02
Depression: HADS [mean (SD)] 4.7 (4) 7.2 (4) 3.5 (4) <0.001
Depression (HADS≥8) [n (%)] 51 (26) 22 (41) 22 (19) 0.002
Age-adjusted and sex-adjusted analyses.
HADS, Hospital Anxiety and Depression Scale; IBD, inﬂammatory bowel disease; IBDQ, Inﬂammatory Bowel Disease Questionnaire; QoL, quality of life; SF-12, 12-item
Short-form Health Survey.
aAs a result of missing data, not all outcomes are for N=202 patients.
bNo paid employment including disability pension, homemaking, study, early retirement and unemployment beneﬁt.
Table 4. Differences in sociodemographic, disease-related, QoL and
work-related factors between employed IBD patients who were and
were not on sick leave in the last 2 weeks
N=123a patients
Sick leave in the
last 2 weeks
(N=31)
No sick leave in the
last 2 weeks
(N=94) P-value
Age (years) 38 40 0.24
Sex (female) (%) 55 46 0.38
Disease activity (yes) 16 12 0.64
Disease duration (years) 14 15 0.46
QoL: SF-12 scores
Physical Component
Score
38 47 <0.001
Mental Component
Score
43 48 0.005
QoL: IBDQ scores
IBDQ total 150 180 <0.001
IBDQ bowel 48 57 <0.001
IBDQ systemic 20 25 <0.001
IBDQ emotional 57 66 0.001
IBDQ social 24 31 <0.001
Anxiety: HADS 7.4 5.2 0.02
Depression: HADS 5.3 3.7 0.04
Presenteeism (days) 4.9 4.6 0.80
Work efﬁciency 6.0 6.8 0.16
Concentration problems 2.0 1.9 0.79
Work slower 2.4 2.1 0.19
HADS, Hospital Anxiety and Depression Scale; IBD, inﬂammatory bowel disease;
IBDQ, Inﬂammatory Bowel Disease Questionnaire; QoL, quality of life; SF-12,
12-item Short-form Health Survey.
aAs a result of missing data, not all outcomes add up to N=123 patients.
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Healthcare utilization and associations with other factors
The occupational physician was visited by 10% of IBD
patients, whereas a GP was visited by 45% of the IBD
patients in the last 4 weeks (Table 5). A physiotherapist
was visited by 13%, whereas 5% of the IBD patients
consulted a social worker. Most IBD patients (51%) paid
one visit to a specialist in the last 4 weeks.
Number of visits to the occupational physician was
associated with sick leave in the last 2 weeks (P<0.0001),
the IBDQ total score (P=0.03), emotional scale
(P=0.003), social scale (P= 0.02), bowel symptoms
(P=0.02), HADS anxiety (P=0.006) and SF-12 mental
score (P=0.10) as indicated by multiple regression
analysis.
The number of visits to the GP was associated with the
IBDQ total score (P=0.04) social scale (P=0.02), sys-
temic symptoms (P=0.02) and the SF-12 physical scores
(P=0.04).
Number of visits to the medical specialist was asso-
ciated with IBDQ total score (P=0.003), emotional scale
(P=0.04), social scale (P< 0.001), systemic symptoms
(P=0.02) and the SF-12 physical scores (P<0.0001).
Visits to the physiotherapist were associated with sick
leave (P=0.001), IBDQ total score (P= 0.02), social scale
(P=0.008), systemic symptoms (P= 0.01) and the SF-12
physical scores (P=0.001). Visits to the social worker
were not related to any of the work-related or QoL factors.
Discussion
The aim of this study was to assess the employment status,
difﬁculties at work and sick leave of IBD patients to
evaluate the relationship between employment status and
sick leave, and sociodemographic and clinical factors,
QoL, anxiety and depressive symptoms, and to assess
healthcare utilization and its associations with work-
related factors and QoL. Results showed that IBD exerts
a detrimental effect on the employment situation of IBD
patients and that most working patients experienced work
difﬁculties. Unfavourable work outcomes such as no paid
employment and being on sick leave were associated with
lower QoL and higher anxiety and depression scores. The
number of visits to the occupational physician was asso-
ciated with sick leave, QoL and anxiety.
Strengths and limitations
A strength of this study is the collection of data on work
difﬁculties as experienced by the IBD patients themselves,
which, to the best of our knowledge, have not been pub-
lished before. The results on experienced work difﬁculties
can provide valuable input for clinicians and for the
development of interventions. A possible limitation of this
study is the cross-sectional design, which does not allow
any conclusions on causal relationships between paid
employment and sick leave, and clinical factors, QoL and
anxiety and depression. Furthermore, the fact that we
included an outpatient population from a highly specia-
lized referral hospital might have inﬂuenced the outcomes
of the study because more patients with a poor prognosis
visited our hospital. Earlier research has shown that
patients with a poor prognosis have higher rates of anxiety
and depression [22,23], which in turn were associated with
less favourable work outcomes in our study. Therefore, the
rates of unemployment might have been higher in our
sample than in other samples from other general hospitals.
Another limitation might be the limited number of patients
in the multiple analyses. We cannot exclude that some
ﬁndings might be based on chance. However, the results
were indicative of a general pattern and therefore under-
score the general conclusion.
Paid employment
In our study, we found that 61% of IBD patients were in
paid employment. In the total Dutch population aged 15
to 64 years, 68% performed paid work for at least 12 h
per week in 2008 [24]. The employment rate among IBD
patients in our sample appears to be slightly lower than
that of the general Dutch population, although samples
were not matched on age, sex and education, and results
were not statistically analysed. It seems plausible that IBD
patients have lower paid employment rates than the gen-
eral population because of the physical, emotional and
social problems that they experience including fatigue,
pain, diarrhoea, embarrassment, anxiety or depression.
Another possibility is the fact that young IBD patients tend
to have less paid jobs during high school than their peers
[25], a trend that persists after high school. We hypothe-
size that this lack of work experience is likely to inﬂuence
the chances of successful employment for IBD patients
after school. More attention to the careers of IBD patients
at a very early stage might positively affect their chances of
paid employment.
The work disability rate in our study was 23% com-
pared with 10% in the general Dutch population [24].
Although samples were not matched on age, sex and
education, disability rates of IBD patients in our sample
seem to be relatively high. Earlier studies in Norway [8],
Hungary [7] and the Netherlands [6] found disability rates
of 19, 32 and 18% (CD patients) and 10% (UC patients),
Table 5. Healthcare utilization: mean number of visits in the last 4 weeks
N=202 patientsa n (%)
Occupational physician
0 181 (90)
1 15 (7)
2 3 (2)
3 or more 3 (2)
General practitioner
0 111 (55)
1 59 (29)
2 20 (10)
3 or more 12 (6)
Physiotherapist
0 175 (87)
1 4 (2)
2 6 (3)
3 or more 17 (8)
Social worker
0 192 (95)
1 6 (3)
2 3 (2)
3 or more 1 (1)
Outpatient visits to a specialist
0 43 (21)
1 102 (51)
2 35 (17)
3 or more 22 (11)
aAs a result of missing data, not all outcomes add up to N=202 patients.
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respectively. Hence, different work disability percentages
are found in different countries and different cohorts.
Differences in social policies, clinical and socioeconomic
circumstances are likely to have inﬂuenced these work
disability rates. Nonetheless, the results of different studies
and countries uniformly indicate that the work disability
rate of IBD patients is higher than that in the general
population.
Work difﬁculties
A remarkable result was that almost half of the patients
who were working reported that their work had been
hindered by health problems in the last 2 weeks while
other difﬁculties at work such as concentration problems
and difﬁculties making decisions at work were frequent. It
is likely that these difﬁculties experienced at work have a
negative impact on the job opportunities and careers of
IBD patients. These results are in line with an earlier sur-
vey of the Work Foundation [26] among 246 patients in
the UK with a chronic disease including IBD patients
(28%), patients with diabetes (13%) and patients with
musculoskeletal disorders (11%). A signiﬁcant proportion
of the respondents highlighted the negative impact that
their chronic condition had on their careers [26], including
not reaching their full potential in the workplace, inhibited
career progression and lower job satisfaction. It is very
likely that the IBD patients in our sample will similarly
suffer from limited career prospects and work satisfaction.
An important adverse effect of IBD on functioning at
work was presenteeism. In our study, the majority of
patients reported that they were at work, but their work
production was delayed, that they had to work slower
than normal and/or that their work had to be done by
others, which are all indicators of presenteeism.
Presenteeism seems to be common among IBD employed
patients because it was similarly reported in a Hungarian
study in 60% of IBD patients, leading to a 28% loss of
work productivity and a 32% activity loss [7].
Presenteeism can also have a severe negative impact on
patients’ life because it is associated with reduced QoL
[27]. Moreover, IBD patients in our study without paid
employment reported lower QoL and higher anxiety and
depression rates than those in paid employment, which is
in line with earlier research from Norway [5].
Interestingly, the sick leave rate in our patients was
quite high, with 25% in the last 2 weeks. However, sick
leave in our study was not associated with disease activity,
which is in contrast to other recent research indicating that
disease course was associated with work disability. [6,7]. It
might be possible that disease activity does not inﬂuence
sick leave because patients go to work irrespective of active
disease, leading to presenteeism and ultimately to work
disability. This possible mechanism is supported by the
ﬁnding that not having paid employment was related to
higher disease activity in our study.
Healthcare utilization
Visits to the occupational physician, GP, physiotherapist
and medical specialist were highly associated with QoL
measured by the IBDQ, and to a lesser extent, with the SF-
12 physical scale and anxiety. This ﬁnding conﬁrms our
earlier research in which we found that poor QoL,
experienced disease burden and depression were sig-
niﬁcantly (P<0.01) associated with more visits to both the
gastroenterologist and the GP [28]. This could imply that
not only the medical symptoms of IBD should be treated
but also anxiety, depression and emotional and social
difﬁculties resulting from having IBD. Furthermore, this
indicates that the IBDQ could be used as a valuable
instrument to detect symptoms and difﬁculties that are
associated with higher healthcare utilization. Those
patients with higher symptom burden and lower func-
tioning should consequently receive more guidance and
support to prevent those unfavourable outcomes.
Implications for research and practice
Most importantly, our study shows opportunities to solve
the work-related difﬁculties encountered by the patients.
Employment outcomes can be improved with innovations
in treatment and with clinical and supportive services
aimed at better management of symptoms and accom-
modation of disabilities [7]. Moreover, if patients keep
participating in work life as much as possible, the chances
of work retention increase signiﬁcantly. Therefore, psy-
chosocial interventions should be developed to enable IBD
patients to solve their difﬁculties at work or to succeed in
appropriate employment as early as possible. This can
improve their social position, ﬁnancial situation, QoL and
prevent development of anxiety and depression sympto-
matology. Similar to other chronic conditions, these
interventions could include multidisciplinary teams [29,30]
of clinicians and nurses.
Clinicians and nurses could also play an important role
in detecting patients at risk because our study has shown
that the indication of patients with possible work difﬁ-
culties can be signalled in the clinic when IBD patients
indicate that they have work-related problems. Clinicians
and nurses could identify patients at risk for work difﬁ-
culties very early in the treatment process and, if indicated,
refer them to occupational professionals such as occupa-
tional physicians or occupational nurses to prevent work-
related problems and associated unfavourable outcomes.
Conclusion
More than half of IBD patients in our study were in paid
employment, whereas almost a quarter was receiving a
disability pension. A large majority of patients at work
experienced difﬁculties such as concentration problems,
having to work slower than normal, having to seclude
themselves from their colleagues and a delay in the pro-
duction of their work. Having no paid employment was
associated with poorer QoL, and more anxiety and
depression symptomatology.
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